Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
ZYME
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
N/A
-0.37
vs -1.19
Q2.23
N/A
-0.76
vs -0.97
Q3.23
N/A
-0.41
vs -0.72
Q4.23
N/A
-0.20
vs 4.65
Q1.24
N/A
-0.42
vs -0.37
Q2.24
N/A
-0.49
vs -0.76
Q3.24
N/A
-0.39
vs -0.41
Q4.24
N/A
-0.31
vs -0.20
Q1.25
N/A
-0.68
vs -0.42
Q2.25
N/A
-0.49
vs -0.49
Sales Growth
YoY
Current
Estimates
Q1.23
+1757%
35.6M vs 1.9M
Q2.23
+29%
7M vs 5.4M
Q3.23
+527%
16.5M vs 2.6M
Q4.23
-96%
16.9M vs 402.5M
Q1.24
-72%
10M vs 35.6M
Q2.24
+175%
19.2M vs 7M
Q3.24
-3%
16M vs 16.5M
Q4.24
+83%
31M vs 16.9M
Q1.25
+105%
20.6M vs 10M
Q2.25
-7%
18M vs 19.2M
Return on Equity
QoQ
Q1.23
-5%
-0.05
vs 0.63
Q2.23
-11%
-0.11
vs -0.05
Q3.23
-7%
-0.07
vs -0.11
Q4.23
-3%
-0.03
vs -0.07
Q1.24
-7%
-0.07
vs -0.03
Q2.24
-9%
-0.09
vs -0.07
Q3.24
-8%
-0.08
vs -0.09
Q4.24
-7%
-0.07
vs -0.08
Institutionnal Ownership
QoQ
Q1.23
118
118
vs 99
19%
Q2.23
141
141
vs 118
19%
Q3.23
142
142
vs 141
1%
Q4.23
156
156
vs 142
10%
Q1.24
169
169
vs 156
8%
Q2.24
164
164
vs 169
-3%
Q3.24
166
166
vs 164
1%
Q4.24
174
174
vs 166
5%
globenewswire.com
6 hours ago
globenewswire.com
6 hours ago
247wallst.com
8 hours ago
247wallst.com
8 hours ago
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Price Target
0.00(-100.00%)
Number of analyst
0
Last analyst upgrade/downgrade
Leerink Partners
upgradePrevious: Not converted
2024-11-07
Now: Outperform
Jefferies
upgradePrevious: Not converted
2022-12-19
Now: Buy
SVB Leerink
downgradePrevious: Not converted
2022-10-21
Now: Market Perform
RBC Capital
initialisePrevious: Not converted
2022-10-21
Now: Outperform
Quote Panel
Key Metrics
Relative Strength
ZYME
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|